Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemolysis | 5 | 2019 | 283 | 1.89 | Why? |
| Hyperbilirubinemia | 2 | 2019 | 81 | 1.59 | Why? |
| Thrombin | 4 | 2021 | 325 | 1.37 | Why? |
| Blood Chemical Analysis | 3 | 2019 | 541 | 1.19 | Why? |
| Lithium | 4 | 2019 | 56 | 1.01 | Why? |
| Hypertriglyceridemia | 2 | 2019 | 90 | 0.91 | Why? |
| Blood Coagulation Tests | 5 | 2021 | 855 | 0.87 | Why? |
| Plasma | 3 | 2019 | 1809 | 0.84 | Why? |
| Blood Specimen Collection | 3 | 2019 | 387 | 0.77 | Why? |
| Jaundice | 2 | 2019 | 114 | 0.76 | Why? |
| Hyperkalemia | 1 | 2019 | 140 | 0.68 | Why? |
| Serum | 1 | 2019 | 294 | 0.67 | Why? |
| Fibrinogen | 4 | 2018 | 1048 | 0.66 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.60 | Why? |
| Blood Gas Analysis | 1 | 2019 | 893 | 0.58 | Why? |
| Immunoassay | 6 | 2021 | 4485 | 0.52 | Why? |
| 2-Propanol | 1 | 2013 | 109 | 0.47 | Why? |
| Mass Spectrometry | 2 | 2017 | 1165 | 0.47 | Why? |
| Troponin I | 2 | 2017 | 1298 | 0.47 | Why? |
| Phlebotomy | 1 | 2013 | 131 | 0.46 | Why? |
| Heparin | 4 | 2019 | 2600 | 0.41 | Why? |
| Chemistry, Clinical | 2 | 2019 | 34 | 0.37 | Why? |
| Running | 4 | 2018 | 153 | 0.36 | Why? |
| Hemostasis | 4 | 2019 | 811 | 0.36 | Why? |
| Physical Endurance | 2 | 2018 | 107 | 0.33 | Why? |
| RNA, Messenger | 4 | 2021 | 5131 | 0.32 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.32 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.27 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2020 | 5993 | 0.26 | Why? |
| Blood Platelets | 3 | 2020 | 1704 | 0.26 | Why? |
| Disinfectants | 1 | 2013 | 1077 | 0.24 | Why? |
| Citric Acid | 2 | 2019 | 116 | 0.23 | Why? |
| Athletes | 3 | 2018 | 1047 | 0.23 | Why? |
| Immunochemistry | 1 | 2019 | 95 | 0.20 | Why? |
| Pre-Analytical Phase | 1 | 2019 | 36 | 0.20 | Why? |
| Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.20 | Why? |
| Erythrocyte Volume | 1 | 2018 | 30 | 0.20 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.20 | Why? |
| Thrombin Time | 1 | 2018 | 46 | 0.20 | Why? |
| Blood Coagulation | 5 | 2020 | 2768 | 0.19 | Why? |
| Chocolate | 1 | 2018 | 23 | 0.19 | Why? |
| Centrifugation | 1 | 2018 | 42 | 0.19 | Why? |
| Erythrocyte Indices | 2 | 2018 | 207 | 0.19 | Why? |
| Piperacillin | 1 | 2017 | 63 | 0.18 | Why? |
| Fatty Acid Binding Protein 3 | 1 | 2016 | 17 | 0.17 | Why? |
| Fluorometry | 1 | 2017 | 47 | 0.17 | Why? |
| Hypercalcemia | 1 | 2017 | 40 | 0.17 | Why? |
| Hemoglobinopathies | 1 | 2017 | 90 | 0.17 | Why? |
| Growth Differentiation Factor 15 | 1 | 2017 | 89 | 0.16 | Why? |
| Chromatography, Liquid | 2 | 2017 | 640 | 0.16 | Why? |
| Bile Acids and Salts | 1 | 2017 | 91 | 0.16 | Why? |
| ADAMTS13 Protein | 1 | 2020 | 363 | 0.16 | Why? |
| Thrombotic Microangiopathies | 1 | 2020 | 335 | 0.16 | Why? |
| Erectile Dysfunction | 1 | 2018 | 141 | 0.16 | Why? |
| Enzyme Assays | 1 | 2017 | 295 | 0.15 | Why? |
| Platelet Function Tests | 1 | 2017 | 231 | 0.15 | Why? |
| Medical Errors | 1 | 2019 | 201 | 0.15 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.15 | Why? |
| Endometrial Neoplasms | 1 | 2017 | 120 | 0.15 | Why? |
| Indicators and Reagents | 1 | 2017 | 183 | 0.15 | Why? |
| Humans | 47 | 2021 | 930598 | 0.14 | Why? |
| Bilirubin | 1 | 2018 | 503 | 0.14 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.14 | Why? |
| Acute-On-Chronic Liver Failure | 1 | 2018 | 237 | 0.14 | Why? |
| Glucose | 1 | 2018 | 573 | 0.14 | Why? |
| MicroRNAs | 2 | 2018 | 1787 | 0.14 | Why? |
| Male | 30 | 2021 | 367725 | 0.13 | Why? |
| Flavonoids | 1 | 2018 | 492 | 0.13 | Why? |
| Graft vs Host Disease | 1 | 2018 | 501 | 0.13 | Why? |
| Amino Acid Oxidoreductases | 1 | 2013 | 10 | 0.13 | Why? |
| Galectin 3 | 1 | 2013 | 76 | 0.13 | Why? |
| Diagnostic Errors | 1 | 2019 | 865 | 0.13 | Why? |
| Blood Cell Count | 1 | 2018 | 1101 | 0.12 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.12 | Why? |
| Lipocalins | 1 | 2012 | 19 | 0.12 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.12 | Why? |
| Renin | 1 | 2013 | 167 | 0.12 | Why? |
| Aldosterone | 1 | 2013 | 155 | 0.11 | Why? |
| Middle Aged | 25 | 2021 | 270681 | 0.11 | Why? |
| Female | 26 | 2021 | 380317 | 0.11 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
| Acute Coronary Syndrome | 2 | 2016 | 2107 | 0.11 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Hemophilia A | 1 | 2017 | 362 | 0.11 | Why? |
| Acute-Phase Proteins | 1 | 2012 | 177 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Sodium | 1 | 2013 | 309 | 0.11 | Why? |
| Adult | 20 | 2021 | 244371 | 0.10 | Why? |
| Potassium | 1 | 2013 | 325 | 0.10 | Why? |
| Proto-Oncogene Proteins | 1 | 2012 | 340 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Folic Acid Deficiency | 1 | 2008 | 22 | 0.09 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.09 | Why? |
| Vitamin B 12 Deficiency | 1 | 2008 | 57 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.09 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.08 | Why? |
| Automation | 2 | 2019 | 429 | 0.08 | Why? |
| Partial Thromboplastin Time | 2 | 2018 | 436 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.08 | Why? |
| Thrombolytic Therapy | 1 | 2018 | 2218 | 0.08 | Why? |
| Particulate Matter | 1 | 2018 | 3249 | 0.07 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| L-Lactate Dehydrogenase | 1 | 2013 | 1995 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Thyroid Diseases | 1 | 2008 | 285 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 2426 | 0.07 | Why? |
| Heart Failure | 2 | 2017 | 6638 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.07 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Aged | 15 | 2021 | 215776 | 0.06 | Why? |
| Internet | 1 | 2019 | 6204 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Lactate Dehydrogenases | 1 | 2020 | 46 | 0.05 | Why? |
| Anticoagulants | 2 | 2019 | 9563 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Calcium Chelating Agents | 1 | 2019 | 2 | 0.05 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.05 | Why? |
| Thrombomodulin | 1 | 2021 | 121 | 0.05 | Why? |
| Italy | 3 | 2021 | 38444 | 0.05 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Luminescence | 1 | 2020 | 236 | 0.05 | Why? |
| Air Pollution | 1 | 2018 | 3504 | 0.05 | Why? |
| Freezing | 1 | 2018 | 106 | 0.05 | Why? |
| Lipase | 1 | 2019 | 153 | 0.04 | Why? |
| Immunoenzyme Techniques | 1 | 2020 | 448 | 0.04 | Why? |
| Ions | 1 | 2017 | 73 | 0.04 | Why? |
| Epidemiologic Research Design | 1 | 2019 | 166 | 0.04 | Why? |
| CA-125 Antigen | 1 | 2017 | 34 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2020 | 536 | 0.04 | Why? |
| Aged, 80 and over | 8 | 2020 | 88759 | 0.04 | Why? |
| Serine Endopeptidases | 1 | 2013 | 4606 | 0.04 | Why? |
| Erythrocyte Count | 1 | 2017 | 137 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.04 | Why? |
| Electrochemical Techniques | 1 | 2020 | 406 | 0.04 | Why? |
| Factor VIII | 1 | 2018 | 229 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Calibration | 1 | 2017 | 307 | 0.04 | Why? |
| Thrombosis | 1 | 2018 | 7504 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Fibrinolysis | 1 | 2021 | 521 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.04 | Why? |
| Serum Albumin | 1 | 2019 | 571 | 0.04 | Why? |
| Brain Edema | 1 | 2018 | 224 | 0.04 | Why? |
| Creatine Kinase | 1 | 2018 | 386 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Self Concept | 1 | 2019 | 490 | 0.04 | Why? |
| Prothrombin Time | 1 | 2017 | 434 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2018 | 757 | 0.04 | Why? |
| Nitrogen Dioxide | 1 | 2018 | 488 | 0.04 | Why? |
| Lactic Acid | 1 | 2018 | 393 | 0.03 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.03 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
| Natriuresis | 1 | 2013 | 7 | 0.03 | Why? |
| Bias | 1 | 2019 | 1109 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2017 | 669 | 0.03 | Why? |
| Contraceptive Agents, Female | 1 | 2013 | 41 | 0.03 | Why? |
| Menstrual Cycle | 1 | 2013 | 59 | 0.03 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 238 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| von Willebrand Factor | 1 | 2018 | 668 | 0.03 | Why? |
| Troponin T | 1 | 2018 | 771 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Lipocalin-2 | 1 | 2012 | 156 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Blotting, Western | 1 | 2013 | 863 | 0.03 | Why? |
| Prostate | 1 | 2013 | 283 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.02 | Why? |
| Proteins | 1 | 2017 | 921 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Biomarkers | 3 | 2017 | 23361 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Prospective Studies | 1 | 2013 | 43301 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.02 | Why? |
| Exosomes | 1 | 2013 | 567 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.02 | Why? |
| Glomerular Filtration Rate | 1 | 2012 | 1262 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Creatinine | 1 | 2012 | 1443 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Sex Characteristics | 1 | 2013 | 1120 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.01 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 7868 | 0.01 | Why? |
| Renin-Angiotensin System | 1 | 2013 | 3661 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2012 | 5762 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Prevalence | 1 | 2008 | 25773 | 0.00 | Why? |
Salvagno's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(226)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_